1

Figure-2

05.17.2020

Related Articles

Future European Collaboration among Health Technology Assessment and Regulatory Agencies

To review highlights of Plenary Session 1 on November 7, 2022: “The Convergence of Health Technology Assessment and Regulation: A New HTA Reality and Collaboration with Regulatory Agencies”.

Read all
Pharma and MedTech Market Access under a National Health Insurance system

Introduction Pharmaceutical and MedTech market access will look vastly different under a South African national health insurance system. A national health insurance system would result in an integrated healthcare system founded on the principles of solidarity and redistribution of healthcare resources. Every South African would contribute to funding the national health insurance system and in […]

Read all
Patient-Centered Research: Challenges in Gathering and Analyzing Patient Experience Data in a Real-World Setting

Introduction The FDA and EMA are committed to gathering more patient experience data for drug approvals and capturing real-world evidence for effectiveness evaluation. This post reviews ISPOR’s second plenary panel discussion in Vienna 2022 on patient-centered research and its challenges in gathering and analyzing patient experience data in a real-world setting, particularly within the EU. […]

Read all
Read all articles